{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:story:51ca9cb3-c80f-4cc4-84bb-a3a3a7adfb7f", "type": "composite", "version": "1", "versioncreated": "2026-11-08T15:50:30.840691Z", "firstcreated": "2026-11-08T15:50:30.840691Z", "pubstatus": "usable", "language": "en", "headline": "Press Reports Say Blood Pressure Benefits of Baxdrostat Last Two Years", "description_text": "A new daily pill called baxdrostat targets a common cause of high blood pressure, and reports suggest some patients kept benefits for up to two years after stopping treatment.", "associations": {"item-0": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:d1961ed3-a8f6-4fa1-846c-5ab64eb57e98", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-11-08T15:50:38.316107Z", "firstcreated": "2026-11-08T15:50:30.840691Z", "pubstatus": "usable", "urgency": 5, "language": "en", "headline": "Press Reports Say Blood Pressure Benefits of Baxdrostat Last Two Years", "byline": "Fiona Montgomery", "located": "United Kingdom", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / The Bizzi Route", "usageterms": "Monitoring item. Headline, short extract and the source link may be shown. Do not republish the full text.", "description_text": "A new daily pill called baxdrostat targets a common cause of high blood pressure, and reports suggest some patients kept benefits for up to two years after stopping treatment.", "altids": {"mosaic": "d1961ed3-a8f6-4fa1-846c-5ab64eb57e98", "story": "51ca9cb3-c80f-4cc4-84bb-a3a3a7adfb7f", "slug": "press-reports-say-blood-pressure-benefits-of-baxdrostat-last-two-years"}, "subject": [{"name": "Society", "rel": "direct", "literal": "society", "code": "medtop:14000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/14000000"}], "place": [{"name": "United Kingdom", "literal": "gb", "code": "GB", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "body_text": "A new daily pill called baxdrostat targets a common cause of high blood pressure, and reports suggest some patients kept benefits for up to two years after stopping treatment.", "extra_body_note": "Extract only — see rights.class = link_only.", "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:079cfa22-27e0-44b5-b20b-99e2ecafa7f6", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "New medication 'cures' high blood pressure cause '2 years after stopping taking it'", "description_text": "Press Reports Say Blood Pressure Benefits of Baxdrostat Last Two Years", "copyrightholder": "i2-prod.mirror.co.uk", "copyrightnotice": "New medication 'cures' high blood pressure cause '2 years after stopping taking it'", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "079cfa22-27e0-44b5-b20b-99e2ecafa7f6"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "RSS source", "licence_verified_at": "2026-11-08T15:50:38.341718Z", "attribution_required": true, "attribution_text": "New medication 'cures' high blood pressure cause '2 years after stopping taking it'", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "i2-prod.mirror.co.uk", "source_url": "https://i2-prod.mirror.co.uk/incoming/article37855842.ece/ALTERNATES/s615/0_GettyImages-1700252021.jpg", "source_page_url": "https://i2-prod.mirror.co.uk/incoming/article37855842.ece/ALTERNATES/s615/0_GettyImages-1700252021.jpg", "our_page_url": "https://thebizziroute.com/society/press-reports-say-blood-pressure-benefits-of-baxdrostat-last-two-years/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://i2-prod.mirror.co.uk/incoming/article37855842.ece/ALTERNATES/s615/0_GettyImages-1700252021.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:51ca9cb3-c80f-4cc4-84bb-a3a3a7adfb7f", "slug": "press-reports-say-blood-pressure-benefits-of-baxdrostat-last-two-years-20261108", "status": "developing", "languages": ["en"], "item_count": 1, "is_breaking": false}, "wireva:rights": {"class": "link_only", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / The Bizzi Route", "canonical_required": true, "canonical_url": "https://thebizziroute.com/society/press-reports-say-blood-pressure-benefits-of-baxdrostat-last-two-years/", "linkback_required": true, "licence": "", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 280, "decided_by_rule": "derivation_failed", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {"editing": true, "drafting": true, "headline": true, "discovery": true, "classification": true, "image_selection": true, "source_collection": true, "cross_source_comparison": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 1, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.", "independence_check": {"status": "failed", "score": 0.75, "checked_at": "2026-11-08T15:50:38.337117Z"}, "sources": [{"url": "https://www.mirror.co.uk/news/health/new-medication-cures-high-blood-37855821", "title": "New medication 'cures' high blood pressure cause '2 years after stopping taking it'", "publisher": "mirror.co.uk", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-11-08T15:50:38.322551Z", "published_at": "2026-11-08T13:39:09Z"}, {"url": "https://www.theguardian.com/society/2026/nov/08/new-drug-high-blood-pressure-baxdrostat", "title": "", "publisher": "theguardian.com", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-11-08T15:50:38.324810Z", "published_at": null}]}, "wireva:publication": {"name": "The Bizzi Route", "domain": "thebizziroute.com", "country": "GB", "url": "https://thebizziroute.com/society/press-reports-say-blood-pressure-benefits-of-baxdrostat-last-two-years/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/d1961ed3-a8f6-4fa1-846c-5ab64eb57e98", "html": "https://wireva.mib.news/item/d1961ed3-a8f6-4fa1-846c-5ab64eb57e98/press-reports-say-blood-pressure-benefits-of-baxdrostat-last-two-years/", "story": "https://wireva.mib.news/story/press-reports-say-blood-pressure-benefits-of-baxdrostat-last-two-years-20261108/"}, "wireva:metrics": {"word_count": 467, "char_count": 2874, "reading_time_seconds": 205}}}}, "extra": {"wireva:languages": ["en"], "wireva:status": "developing", "wireva:item_count": 1}}